Amit Sharma, Dhruv Maini, Gaurang Agarwal, Parul Sharma, Lalit Maini

Fibrodysplasia ossificans progressiva – can we diagnose it right at the outset?

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominantdisorder with no definitive treatment options available yet, except forphysiotherapy and bisphosphonates. Due to its initial presentation withmultiple lumps in the body, it is often misdiagnosed as a benign tumour mostcommonly being an osteochondroma or Olliers syndrome. Delay in diagnosisnot only delays the management but can also expose the patient to unnecessaryinterventions. Moreover, earlier diagnosis can also make the patient aware ofthe precautions to be taken. So our remark is “can we diagnose this diseaseright at the outset”? We present a case of a 10 year old boy, who had all theclassical features of FOP yet was misdiagnosed. Therefore, classical hallmarkfeatures of this disease are highlighted in this case report which can be pickedup easily by any clinician to reach to a definitive diagnosis as early as possibleavoiding unnecessary iatrogenic insult.

PDF

___

1. Whyte MP. Heritable metabolic and dysplastic bone diseases. Endocrinol Metab Clin North Am 1990; 19: 133-173.
2. Connor JM, Evans DA. Genetic aspects of fibrodysplasia ossificans progressiva. J Med Genet 1982; 19: 35-39.
3. Pignolo RJ, Suda RK, Kaplan FS. The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metabol 2005; 3: 195-200.
4. Palhares DB, Leme LM. A perspective on the control of myositis ossificans progressiva. J Pediatr (Rio J) 2001; 77: 431-434.
5. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006; 38: 525-527.
6. Cohen RB, Hahn GV, Tabas JA, et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Joint Surg Am 1993; 75: 215-219.
7. Kaplan FS, Glaser DL, Shore EM, et al. The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005; 3: 183-188.
8. Kaplan FS, Glaser DL. Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005; 3: 213-216.
9. Kitterman JA, Kantanie S, Rocke DM, Kaplan FS. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 2005; 116: e654–e661.
10. Tederko P, Krasuski M, Kiwerski J, Barcinska I. The importance of verifying diagnosis in patients with spinal cord injury hospitalized in a rehabilitation department. Ortho Traumatol Rehabil 2005; 7: 365- 373.
11. Kapoor R, Gadre PM, Mattoo P, Agrawal R. Fibrodysplasia ossificans progressiva. Indian Pediatr 1998; 35: 786-788.
12. Oshin AO, Stewart MC. The role of bone morphogenetic proteins in articular cartilage development, homeostasis and repair. Vet Comp Orthop Traumatol 2007; 20: 151-158.